Nasdaq Grants Revelation Biosciences Inc. Continued Listing
Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...
C&EN6d
Exploring the Impact of Amidation Status in Meso-Diaminopimelic-Acid-Containing Disaccharide Peptidoglycan Fragments on Host Innate Immune Activation
School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore 637371, Singapore ...
Medscape5d
Combination Therapy for Patients with Type 2 Diabetes: Repaglinide in Combination with Metformin
Drug–drug interactions between antidiabetic agents and other pharmacological compounds may be two-sided. For those antidiabetic drugs that are metabolized via the CYP450 isoenzymes, concomitant ...